Clinical development plan: 13-cis-retinoic acid.
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004285:Dogs; D017277:Drug Approval; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000517:prevention & control; D051381:Rats; D012107:Research Design
D016588:Anticarcinogenic Agents; D015474:Isotretinoin